MICHAEL N. MCCARTY LAW OFFICE PLLC for AMERICAN MEDICAL TECHNOLOGISTS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Legislation affecting payments under the Medicare Clinical Laboratory Fee Schedule; coronavirus relief and stimulus legislation as it affects payment for clinical laboratory testing services. Oppose the Strictly Pay for Efficient and Expedited Delivery of Your (SPEEDY) COVID-19 Tests Act (H.R. 8496).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL N MCCARTY | — |
Medical/Disease Research/Clinical Labs MED
Legislation to regulate in vitro clinical diagnostic tests, including the Verifying Accurate, Leading-edge IVCT Development (VALID) Act (H.R.6102; S.3404); and the Verified Innovative Testing in American Laboratories (VITAL) Act (S.3512); Coronavirus relief and stimulus legislation as it relates to clinical laboratories and medical practices; coronavirus testing and vaccine supply chain issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL N MCCARTY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.